Close Menu

New Journal in Town

A new scientific journal backed by venture capitalist Tim O'Reilly relies on a one-time fee for researchers to be able to publish articles there, reports Reuters. The journal, called PeerJ, is the brainchild of Peter Binfield — formerly of PLoS One — and Jason Hoyt — formerly at Mendeley — and it will focus on the biological and medical sciences.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.